Skip to main
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

Addus HomeCare is well-positioned for growth in the in-home care market as it generates a majority of revenue from the rapidly growing Personal Care segment, and has a strong presence in the hospice and home health segments. However, potential program and policy changes in its revenue sources, such as Medicaid and Medicare, could impact margins and growth. Integration challenges from its recent acquisition of Gentiva and labor constraints in its clinical businesses may also pose risks to achieving its target price. Overall, the company's strong fundamentals and potential for an uptick in acquisition activity make it a solid choice for investors.

Bears say

Addus HomeCare is facing potential headwinds in its personal care segment due to changes in policies and reimbursement rates, which could negatively impact its margins and financial performance. The company's strategy focused on acquisitions, rather than organic growth, also poses integration risks that could affect its future financial projections. Additionally, approximately 20% of the company's revenue comes from its participation in the Illinois CCP, making it vulnerable to any changes in that program.

Addus HomeCare (ADUS) has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 8 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Jun 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $132.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $132.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.